Founded in 2013, Co-founder Dr. Nader Nourizad, A pioneer in pyrosequencing and enzyme engineering, believed the market was in desperate need of high quality, high yield, and above all else, truly pure reagents.
Pharmozyme has since developed proprietary technology to produce the world’s purest reagents, introducing the world’s first Taq Polymerase free from bacterial and animal DNA contamination. In the coming years Pharmozyme plans to release a variety of contamination free reagents, supporting new technologies in sequencing and DNA research. Its future path will include the production of highly accurate and sensitive kits for medical diagnostics.
Pharmozyme Inc. manufactures and sells the world’s purest enzymes that are free from bacterial and animal DNA contamination, used for supporting new technologies in DNA Amplification, Sequencing research and production of highly accurate and sensitive pathogen detection kits.
Pharmozyme’s mission is to significantly improve the lives of human beings through the development of novel, effective, and accessible solutions for the biotech community. By providing the highest quality enzymes and customer service, we strive to help genetic research and diagnostic labs thrive.
Dr. Ronald Davis
DIRECTOR, STANFORD GENOME TECHNOLOGY CENTER
MANAGING DIRECTOR AT PARADIGM BIOVENTURES
EXECUTIVE GLOBAL MARKETING AND COMMERCIAL ADVISOR
EVP GILEAD MEDICAL AFFAIRS & EMERGING MARKETS
TECHNOLOGY DIRECTOR, OFFICE OF TECHNOLOGY TRANSFER, HOUSTON METHODIST HOSPITAL
Dr. Molly He
MANAGING PARTNER OF ROMULUS GLOBAL ISSUES MANAGEMENT